PulmoLife is a new COPD screening device, designed for quick and easy screening of adult smokers for early detection of COPD. Smokers are at the greatest risk of developing COPD and decline in lung function in susceptible smokers has been shown to be twice that of non-smokers. This small, innovative device measures FEV1, the measurement of choice in COPD screening. The unit will display a patient’s result together with the FEV1 as a percentage of their predicted value. These results are used to calculate a ‘Lung Age’. The associated ‘Lung Age’ graphical display may help the patient realise the physical damage caused by smoking, encouraging attendance for smoking cessation advice and full spirometry assessment, leading to early diagnosis and appropriate management of COPD.
FEV1 and FEV1 % predicted Forced Expiratory Volume in the First Second of Expiration. The use of FEV1 is well documented as a useful diagnostic tool for the detection of early COPD. When comparing its result against predicted values and using patients FEV1 result as a percentage of predicted values (FEV1 % predicted) the likelihood and severity of COPD can be seen.
Features and Benefits
- Measures FEV1 – the measurement of choice in COPD screening.
- Gives FEV1 result as a percentage of predicted values.
- ‘Lung Age’ Interpretation (Morris and Temple).
- Used as a motivational tool for smoking cessation.
Technical Specifications
- Transducer: Micro direct gold standard bi-directional digital volume.
- Resolution: 10ml.
- Accuracy: +/-3% (meets and exceeds all known spirometry performance standards)
- Volume Range: 0-8 Liters.
- Flow Range: 0-8 Liters.
- Display: Custom Liquid Crystal.
- Power Supply: 3V Lithium Ion Coin Cell Battery.
- Dimensions: 5.1" x 2.3" x 1.5"
- Weight: 3.4 oz.
Source:MicroDirect